Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-021233
Filing Date
2019-03-25
Accepted
2019-03-25 18:54:24
Documents
1
Period of Report
2019-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4003
  Complete submission text file 0001209191-19-021233.txt   5300
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address
Hemrajani Rekha (Reporting) CIK: 0001771213 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38419 | Film No.: 19703732